APA (7th ed.) Citation

Lee, C., Huang, P., Hsieh, Y., Chen, Y., & Tsai, J. Melatonin combined with sorafenib synergistically inhibit the invasive ability through targeting metastasis-associated protein 2 expression in human renal cancer cells. Wolters Kluwer Medknow Publications.

Chicago Style (17th ed.) Citation

Lee, Chu-Che, Po-Yu Huang, Yi-Hsien Hsieh, Yong-Syuan Chen, and Jen-Pi Tsai. Melatonin Combined with Sorafenib Synergistically Inhibit the Invasive Ability Through Targeting Metastasis-associated Protein 2 Expression in Human Renal Cancer Cells. Wolters Kluwer Medknow Publications.

MLA (9th ed.) Citation

Lee, Chu-Che, et al. Melatonin Combined with Sorafenib Synergistically Inhibit the Invasive Ability Through Targeting Metastasis-associated Protein 2 Expression in Human Renal Cancer Cells. Wolters Kluwer Medknow Publications.